Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Cassava, Alzheimer and SEC
Alzheimer’s Drug Developer Cassava Paying $40 Million to Settle Doctored Data Claims
The Securities and Exchange Commission alleged that a researcher for the company manipulated trial data to make its drug results look more promising.
Cassava Sciences shares fall after SEC charges for misleading Alzheimer's drug trial claims
WASHINGTON (Reuters) -Shares of Cassava Sciences fell 10% in post-market trading on Thursday after the U.S. Securities and Exchange Commission charged the biopharmaceutical company and two former executives for misleading claims about the results of Alzheimer's clinical trials.
Cassava Sciences settles SEC charges of ‘misleading’ Alzheimer’s trial claims
Shares of Cassava Sciences Inc. dropped more than 10% in the extended session Thursday after announcing a settlement with U.S. securities regulators, who had charged the pharma company and two former executives for “misleading claims” about an Alzheimer’s clinical trial.
studyfinds
12h
Alzheimer’s drug breakthrough or breakdown? Investigation exposes red flags in FDA approval of donanemab
A startling investigation has revealed a troubling story behind donanemab's approval -- one of questionable data, potential ...
Afro
5h
Neurologist speaks on fighting Alzheimer’s Disease with diet and exercise
Discover how exercise, a healthy diet, and socialization can help combat Alzheimer's disease. Learn more about the importance ...
STAT
5h
Medicare will continue its cautious approach to paying for Alzheimer’s drugs
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...
McKnight's Long-Term Care News
3h
Journalists question safety and effectiveness of new Alzheimer’s drug
A report published Wednesday in The BMJ questioned the safety and effectiveness of the Alzheimer’s disease drug Kisunla ...
3h
Walk to End Alzheimer’s coming to Marquette
The internationally held walk is the world’s largest fundraiser for Alzheimer’s care, support, and research. As of Friday, ...
KJZZ
1h
This guide is designed for voters who have Alzheimer's, cognitive disorders
Arizonans will be casting their ballots very soon and that might include individuals living with Alzheimer’s disease or some ...
1d
Questions over safety and effectiveness of new Alzheimer's drug
The safety and effectiveness of donanemab—an Alzheimer's drug recently approved by the US Food & Drug Administration (FDA)—is ...
FOX 34
5h
Walk to End Alzheimer's on Oct 5 at Adventure Park
Held annually in more than 600 communities nationwide, the Alzheimer’s Association Walk to End Alzheimer’s® is the world’s ...
1d
New Alzheimer’s Therapy Shows Remarkable Results in Animal Trials
A study from TUM demonstrates a promising therapeutic approach. Researchers at the Technical University of Munich (TUM) have ...
6h
Dietary compound increases longevity and protects against Alzheimer's disease in experimental models
Researchers from the Color and Food Quality group at the Faculty of Pharmacy (University of Seville), in collaboration with ...
19h
on MSN
Couple named ambassadors of Alzheimer's charity
A couple living with Alzheimer’s have been made ambassadors of a research charity. Frank and Alison Littleford, from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Japan
dementia
Cassava Sciences
Barbara Corcoran
Walk
Feedback